Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Michael Kirshenbaum, M.D.

Co-Author

This page shows the publications co-authored by James Kirshenbaum and Elliott Antman.
Connection Strength

0.127
  1. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy. J Am Coll Cardiol. 1988 Sep; 12(3):773-80.
    View in: PubMed
    Score: 0.097
  2. Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia. Circulation. 1985 Oct; 72(4):873-80.
    View in: PubMed
    Score: 0.020
  3. The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agent. Eur J Nucl Med. 1986; 12(5-6):219-25.
    View in: PubMed
    Score: 0.005
  4. Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia. Am J Cardiol. 1985 Oct 23; 56(11):40F-48F.
    View in: PubMed
    Score: 0.005
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.